Page last updated: 2024-09-04

cyc 202 and z-val-ala-asp(ome)-fluoromethylketone

cyc 202 has been researched along with z-val-ala-asp(ome)-fluoromethylketone in 1 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(z-val-ala-asp(ome)-fluoromethylketone)
Trials
(z-val-ala-asp(ome)-fluoromethylketone)
Recent Studies (post-2010) (z-val-ala-asp(ome)-fluoromethylketone)
97973933309

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, X; Mao, Z; Park, D; Tang, X; Tong, M; Wang, X; Xia, Z1

Other Studies

1 other study(ies) available for cyc 202 and z-val-ala-asp(ome)-fluoromethylketone

ArticleYear
Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, May-11, Volume: 25, Issue:19

    Topics: Amino Acid Chloromethyl Ketones; Animals; Animals, Newborn; Blotting, Western; Caspase Inhibitors; Caspases; Cell Count; Cell Death; Cells, Cultured; Cerebellum; Chromatin; Cyclin-Dependent Kinase 5; Drug Interactions; Glutamic Acid; Green Fluorescent Proteins; Luciferases; MEF2 Transcription Factors; Myogenic Regulatory Factors; Neurons; Neurotoxins; Oligopeptides; Protein Kinase Inhibitors; Purines; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Roscovitine; Subcellular Fractions; Time Factors; Transfection

2005